83. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Freitag, 21. April 2017 (Posterbereich 14) 16:00-17:30

Postervorträge

Medikamentöse Therapie

Diskussionsleiter: R. Wachter (Göttingen)

(P1408) Beta blockers and chronic heart failure patients – prognostic impact of a dose targeted beta blocker therapy vs. heart rate targeted strategy.
    A. Corletto, H. Fröhlich, T. Täger, M. Hochadel, H. A. Katus, L. Frankenstein, J. Senges (Heidelberg, Ludwigshafen)
(P1409) The true rate of drug-related cough of the angiotensin converting enzyme inhibitors in placebo controlled trials in cardiovascular medicine: a meta-analysis
    D. Vukadinovic, D. Lavall, A. Nikolovska Vukadinovic, S. Wagenpfeil, M. Böhm (Homburg/Saar, Homburg)
(P1410) Treatment with sacubitril/valsartan regarding evaluation for heart transplantation
    F. Strangl, M. Rybczynski (Hamburg)
(P1411) Evaluating Internal Medicine Patients’ Comprehensibility of a Standardized Medication Plan (§ 31a SGB V)
    L. Botermann, K. Monzel, K. Krueger, C. Eickhoff, A. Wachter, C. Kloft, U. Laufs, M. Schulz (Berlin, Homburg/Saar)
(P1412) Adverse effects of escitalopram on cardiac status and health-related quality of life in the MOOD-HF study depend on heart failure severity at baseline – results of a secondary subgroup analysis
    D. Knappe, S. Sehner, S. Störk, H. Gunold, F. Edelmann, R. Wachter, H. Schunkert, T. Graf, I. Kindermann, M. Haass, S. Blankenberg, S. Pankuweit, C. Prettin, M. Böhm, H. Faller, J. Deckert, K. Wegscheider, G. Ertl, C. E. Angermann, MOOD-HF (Hamburg, Würzburg, Leipzig, Berlin, Göttingen, München, Lübeck, Homburg/Saar, Mannheim, Marburg)
(P1413) Impact of Pulmonary Function on Patient-Reported State of Health in Patients with Heart Failure
    K. Rothmund, N. Nagysomkuti-Merste, M. Breunig, C. Morbach, G. Ertl, C. E. Angermann, S. Störk, F. H. Rutten, G. Güder, S. Brenner, INH (Würzburg; Utrecht, NL)